ALTO-207 in Adults With Treatment-resistant Depression (TRD)
This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom and the United States.
Multiple locations, including Birmingham
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom and the United States.
Multiple locations, including BirminghamThis study is recruiting in the United Kingdom. It is testing its effects on mood for Anxiety.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on addiction and currently lists participation information in the United States.
In TulsaThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In AlbuquerqueThis study is recruiting. It focuses on depression and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In St LouisThis study is recruiting. It focuses on depression and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In PittsburghThis study is recruiting in the United Kingdom. It focuses on Depression.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
Multiple locations, including Garden GroveHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.